Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
HAPILA GmbH logo — innovation and experience

HAPILA GmbH

innovation and experience

Founded 2007 12 employees Seed Biotechnology, Health Care +1

General Information

Company Name HAPILA GmbH
Founded Year 2007
Employees 12
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with HAPILA GmbH. To contact HAPILA GmbH, visit hapila.de.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does HAPILA GmbH compare?

A PDF of HAPILA GmbH and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting HAPILA GmbH soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About HAPILA GmbH

HAPILA GmbH is a biotechnology, healthcare, and pharmaceutical startup, founded in 2007 with the slogan of "innovation and experience." The company, led by scientists and technicians with extensive experience in the pharmaceutical industry, has achieved significant growth and has established a successful business organization with an international client base. HAPILA specializes in contract development and manufacturing (CDMO) of active pharmaceutical ingredients (APIs) for pharmaceutical, biotech, and fine chemical clients. Their proprietary HAPIpur® technology is protected by European and US patents, demonstrating their commitment to innovation and development. In September 2008, HAPILA received a Seed Round investment from HTGF | High-Tech Gruenderfonds, which signifies the confidence of notable investors in the company's potential. The company's focus on compliance with Good Manufacturing Practice (GMP) and environmental guidelines, as well as their in-house API production at a GMP certified facility in Gera, Thuringia, Germany, reflects their dedication to quality, potency, and safety in the pharmaceutical industry. HAPILA aims to be a highly efficient bridge-builder between API production and pharmaceutical end-use, emphasizing on delivering superior quality products and ensuring customer satisfaction. With its compelling vision and strong foundation, HAPILA is well-positioned to make a significant impact in the biotechnology and pharmaceutical sectors.

Business keywords: pharmaceutical industry, API manufacturing, GMP certification, CDMO, process development, clinical studies, patented technology, particle design, chemical synthesis, analytical method development, scale-up, trustworthy, cooperation, flexibility, innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round Undisclosed 1
HTGF | High-Tech Gruenderfonds
23 Sep 2008

HAPILA GmbH Alternatives & Competitors

View All Alternatives
HAPILA GmbH vs
Corealis Pharma Inc.
Corealis Pharma Inc. Canada

Formulation Development and Clinical Supply Manufacturing

Venture round
44 employees
Health Care, Manufacturing
HAPILA GmbH vs
Biokey, Inc.
Biokey, Inc. United States

A Global CDMO Service Provider for Nutritional And Pharmaceutical Products

9 employees
Biotechnology, Manufacturing
HAPILA GmbH vs
Avra Laboratories Pvt Ltd
Avra Laboratories Pvt Ltd India

Custom Synthesis from Idea to Market

210 employees
Biotechnology, Health Care
View all alternatives

FAQ About HAPILA GmbH

innovation and experience
HAPILA GmbH was founded in 2007.
HAPILA GmbH operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on pharmaceutical industry, API manufacturing, GMP certification and CDMO.
HAPILA GmbH has approximately 12 employees.
HAPILA GmbH has completed 1 funding round. The latest funding stage is Seed.
Top alternatives and competitors to HAPILA GmbH include Corealis Pharma Inc., Biokey, Inc., Avra Laboratories Pvt Ltd, CiVentiChem, Hongene Biotech Corporation. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
HAPILA GmbH and Corealis Pharma Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for HAPILA GmbH, https://bouncewatch.com/company/hapila-gmbh, updated 31 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes